Log in to save to my catalogue

Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treat...

Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2c35682e937f49e18c10256c278fef57

Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study

About this item

Full title

Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study

Publisher

England: BioMed Central Ltd

Journal title

Journal of medical case reports, 2019-10, Vol.13 (1), p.314-314, Article 314

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

To determine the prevalence of and risk factors for malignant transformation of ovarian endometrioma during dienogest therapy, which is very rare, we examined multiple cases of malignant transformation of ovarian endometrioma during dienogest therapy and performed a multivariate analysis of the records in our hospital.
The medical records of 174...

Alternative Titles

Full title

Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2c35682e937f49e18c10256c278fef57

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2c35682e937f49e18c10256c278fef57

Other Identifiers

ISSN

1752-1947

E-ISSN

1752-1947

DOI

10.1186/s13256-019-2236-z

How to access this item